Heilongjiang Provincial Drug Administration issued a document to remove restrictions on distance between pharmacies and many places have started

drug regulatory agency to remove the pharmacy spacing restrictionsOn December 1, Heilongjiang Provincial Drug Administration issued a Notice on The Optimization of The Opening and Approval of Pharmaceutical Operations (Retail) Enterprises (hereinafter referred to as the Notice).According to the Notice, according to the State Council and the provincial government on deepening the reform of "management services" to optimize the deployment of business environment work, after study, the Bureau decided to further optimize the province-wide pharmaceutical business (retail) enterprises to open approval work."Notice" clearly, optimize drug business (retail) license opening approval, cancel the drug retail chain stores, drug retail enterprises to prepare for the establishment of approval, application to open only Class B over-the-counter drug retail stores and drug retail enterprises to implement the notification commitment system, not to set spacing restrictions on the opening of pharmacies and other unreasonable conditions.At the same time, "Notice" also talked about, to enhance the optimization of administrative licensing services awareness, vigorously promote "online approval" "do not meet approval" "zero run" "run at most once", according to the actual further compression of the approval time limit, reduce the declaration materials, approval process and approval links;

the spacing limit, the whole country shouldIn fact, Heilongjiang Province to cancel the pharmacy preparation approval, spacing restrictions, etc. , is also expected. As early as last month, the General Office of the State Council issued the "national deepening of "management services" reform to optimize the business environment teleconsecond key tasks division of labor program" to talk about this point.The program points out that nationwide, the application for the establishment of only Class B over-the-counter drug retail enterprises to implement the notification commitment system, promote the cancellation of drug retail enterprises to prepare for approval, urge the local clean-up of the opening of pharmacies set spacing restrictions and other unreasonable conditions, and with the strengthening of after-the-fact supervision.From the point of view of this measure, mainly involves three major interests: First, only the enterprise operating Class B OTC approval to implement the notification commitment system;

announced that the cancellation of the preparation and approvalIn addition to Heilongjiang, Zhejiang, Liaoning and other places have been clear, the cancellation of pharmacy preparation and approval.According to zhejiang Province's "Announcement on the suspension of the implementation of administrative licensing matters for pharmaceutical enterprises in the province", from September 25, 2020, the province suspended the implementation of "drug business (wholesale) enterprises to build", "drug business (retail) enterprises (chain enterprises) to build" "drug business (retail) enterprises (chain stores, single pharmacies) to prepare for construction" and other three administrative licensing matters.After the suspension is implemented, the applicant only needs to declare the licensing matters of "drug business (wholesale) enterprise acceptance", apply for the establishment of the drug retail chain headquarters, only declare the "drug business (retail) enterprise (chain enterprise) acceptance" licensing matters, apply for the opening of drug chain stores, single pharmacies, only declare "drug business (retail) enterprise (chain stores, single pharmacy) acceptance" licensing matters.On March 26 this year, the Liaoning Provincial Drug Administration issued the "announcement on the cancellation of the approval of pharmaceutical business enterprises to prepare for the establishment of preparation and approval matters", in order to further optimize the business environment, streamline the opening of pharmaceutical business enterprises approval process, in accordance with the spirit of the decision to cancel the pharmaceutical business enterprises (drug wholesale, retail enterprises) to apply for the "drug business license" in the preparation and approval.The source pointed out that newly launched pharmaceutical business enterprises, eligible for application can directly apply for the issue of "drug business license." At the same time, the drug regulatory department will no longer accept applications for the establishment of new drug-operating enterprises, and will no longer issue decisions on the preparation and construction. (Pharmacy manager
)